Company: DERM
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041214
Chunk: 35

Company: Journey Medical Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 35
---
standingOptions,Warrants andRights ($)(2) 
 (b)                                                                          |   |      |   | ​ 
 ​ | ​ 
 ​ | Number ofSecuritiesRemainingAvailable forFuture Issuanceunder EquityCompensationPlans ExcludingSecurities Reflectedin Column (a)(3) 
 (c)                                                                                                                                 |   |           |   | ​ 
 ​ |
|:------------------------------------------------------------|:--|:--|:--------------------------------------------------------------------------------------------|:--|----------:|:--|:--|:--|:-----------------------------------------------------------------------------|:--|-----:|:--|:--|:--|:------------------------------------------------------------------------------------------------------------------------------------|:--|----------:|:--|:--|
| Equity compensation plans approved by security holders:     | ​ | ​ | ​                                                                                           | ​ | 4,811,906 | ​ | ​ | ​ | ​                                                                            | $ | 1.41 | ​ | ​ | ​ | ​                                                                                                                                   | ​ | 3,036,110 | ​ | ​ |
| Equity compensation plans not approved by security holders: | ​ | ​ | ​                                                                                           | ​ |         — | ​ | ​ | ​ | ​                                                                            | ​ |    — | ​ | ​ | ​ | ​                                                                                                                                   | ​ |         — | ​ | ​ |
| Total:                                                      | ​ | ​ | ​                                                                                           | ​ | 4,811,906 | ​ | ​ | ​ | ​                                                                            | $ | 1.41 | ​ | ​ | ​ | ​                                                                                                                                   | ​ | 3,036,110 | ​ | ​ |

(1) Reflects the number of shares of common stock to be issued upon exercise of 2,471,945 stock options and upon settlement of 2,339,961 restricted stock units outstanding under the 2015 Plan. (2) Does not take into account outstanding restricted stock units, which have no exercise price. (3) Reflects 2,820,574 shares available for future issuance under the 2015 Plan and 215,536 shares available for future issuance under the ESPP.

20

TABLE OF CONTENTS

DIRECTOR COMPENSATION Director Compensation Program In July 2021, we adopted a Non-Employee Directors Compensation Plan for our non-employee directors. Pursuant to that Plan, our non-employee directors receive the following compensation for service on the Board: Cash Compensation: • $50,000 annual retainer, paid quarterly in advance; and • $10,000 additional annual